
Nuevocor draws $45M series B for gene therapy in rare heart disease
Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the treatment of an inherited form of cardiomyopathy. BioWorld BioWorld Asia Science Clinical Financings Cardiovascular Gene therapy …